These restrictions in the BTNX NTS are really related, as we observed e.g. etodesnitazene to have an identical in vitro potency and efficacy as fentanyl [7, 13] and as it might perhaps give PWUD a Bogus feeling of security. Moreover, the detectability of nitazene analogues in drug samples can be impacted by solubility challenges, as highlighted via